HEADER OXIDOREDUCTASE 05-JUN-02 1LXC TITLE CRYSTAL STRUCTURE OF E. COLI ENOYL REDUCTASE-NAD+ WITH A BOUND TITLE 2 ACRYLAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NADH-DEPENDENT ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562 KEYWDS FABI, ENOYL REDUCTASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR W.H.MILLER,M.A.SEEFELD,K.A.NEWLANDER,I.N.UZINSKAS,W.J.BURGESS, AUTHOR 2 D.A.HEERDING,C.C.K.YUAN,M.S.HEAD,D.J.PAYNE,S.F.RITTENHOUSE, AUTHOR 3 T.D.MOORE,S.C.PEARSON,V.DEWOLF,W.E.BERRY,P.M.KELLER,B.J.POLIZZI, AUTHOR 4 X.QIU,C.A.JANSON,W.F.HUFFMAN REVDAT 5 14-FEB-24 1LXC 1 REMARK REVDAT 4 13-JUL-11 1LXC 1 VERSN REVDAT 3 24-FEB-09 1LXC 1 VERSN REVDAT 2 01-APR-03 1LXC 1 JRNL REVDAT 1 04-SEP-02 1LXC 0 JRNL AUTH W.H.MILLER,M.A.SEEFELD,K.A.NEWLANDER,I.N.UZINSKAS, JRNL AUTH 2 W.J.BURGESS,D.A.HEERDING,C.C.YUAN,M.S.HEAD,D.J.PAYNE, JRNL AUTH 3 S.F.RITTENHOUSE,T.D.MOORE,S.C.PEARSON,V.BERRY, JRNL AUTH 4 W.E.DEWOLF JR.,P.M.KELLER,B.J.POLIZZI,X.QIU,C.A.JANSON, JRNL AUTH 5 W.F.HUFFMAN JRNL TITL DISCOVERY OF AMINOPYRIDINE-BASED INHIBITORS OF BACTERIAL JRNL TITL 2 ENOYL-ACP REDUCTASE (FABI). JRNL REF J.MED.CHEM. V. 45 3246 2002 JRNL REFN ISSN 0022-2623 JRNL PMID 12109908 JRNL DOI 10.1021/JM020050+ REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 82.3 REMARK 3 NUMBER OF REFLECTIONS : 20569 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 909 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 25014 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 46.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1680 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE : 0.2555 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 24 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3729 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 136 REMARK 3 SOLVENT ATOMS : 300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.60000 REMARK 3 B22 (A**2) : 3.60000 REMARK 3 B33 (A**2) : -7.20000 REMARK 3 B12 (A**2) : 0.58000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : 805.PARAM REMARK 3 PARAMETER FILE 3 : NAD.PARAM REMARK 3 PARAMETER FILE 4 : WATER.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LXC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JUN-02. REMARK 100 THE DEPOSITION ID IS D_1000016375. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20621 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.1 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 43.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.09800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: 1C14 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, 2M(NH4)2SO4,5% PEG400, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 108.72333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 217.44667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 163.08500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 271.80833 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.36167 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 108.72333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 217.44667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 271.80833 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 163.08500 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 54.36167 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CAONTAINS A DIMER OF THE TERNARY COMPLEX REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 22590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -132.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 39.79000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 68.91830 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 271.80833 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 196 REMARK 465 ALA A 197 REMARK 465 SER A 198 REMARK 465 GLY A 199 REMARK 465 ILE A 200 REMARK 465 LYS A 201 REMARK 465 ASP A 202 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 LYS A 262 REMARK 465 MET B 1 REMARK 465 ALA B 196 REMARK 465 ALA B 197 REMARK 465 SER B 198 REMARK 465 GLY B 199 REMARK 465 ILE B 200 REMARK 465 LYS B 201 REMARK 465 ASP B 202 REMARK 465 GLU B 260 REMARK 465 LEU B 261 REMARK 465 LYS B 262 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 195 CG CD1 CD2 REMARK 470 LYS A 205 CG CD CE NZ REMARK 470 ARG B 204 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 205 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 42 -39.32 -39.31 REMARK 500 LYS A 43 -9.93 -52.64 REMARK 500 ASP A 103 128.90 -39.56 REMARK 500 SER A 121 -52.62 -122.63 REMARK 500 ASN A 155 -22.51 72.33 REMARK 500 ASN A 157 -124.95 38.27 REMARK 500 VAL A 247 76.11 -119.99 REMARK 500 PHE B 3 15.35 -68.57 REMARK 500 VAL B 65 -6.98 -55.09 REMARK 500 SER B 91 55.57 -118.18 REMARK 500 ASP B 98 -9.55 -58.34 REMARK 500 LEU B 100 51.21 -94.39 REMARK 500 SER B 121 -50.05 -123.60 REMARK 500 ASN B 155 -21.81 67.38 REMARK 500 ASN B 157 -117.57 29.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AYM A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AYM B 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C14 RELATED DB: PDB REMARK 900 1C14 IS THE CRYSTAL STRUCTURE OF E COLI ENOYL REDUCTASE-NAD+- REMARK 900 TRICLOSAN COMPLEX REMARK 900 RELATED ID: 1I2Z RELATED DB: PDB REMARK 900 1I2Z IS E. COLI ENOYL REDUCTASE IN COMPLEX WITH NAD AND BRL-12654 REMARK 900 RELATED ID: 1I30 RELATED DB: PDB REMARK 900 1I30 IS E. COLI ENOYL REDUCTASE +NAD+SB385826 REMARK 900 RELATED ID: 1QG6 RELATED DB: PDB REMARK 900 1QG6 IS THE CRYSTAL STRUCTURE OF E. COLI ENOYL ACYL CARRIER PROTEIN REMARK 900 REDUCTASE IN COMPLEX WITH NAD AND TRICLOSAN REMARK 900 RELATED ID: 1LX6 RELATED DB: PDB REMARK 900 1LX6 IS THE CRYSTAL STRUCTURE OF E. COLI ENOYL REDUCTASE-NAD+ WITH REMARK 900 A BOUND BENZAMIDE INHIBITOR DBREF 1LXC A 1 262 UNP P29132 FABI_ECOLI 0 261 DBREF 1LXC B 1 262 UNP P29132 FABI_ECOLI 0 261 SEQRES 1 A 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 A 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 A 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 A 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 A 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 A 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 A 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 A 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 A 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 A 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 A 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 A 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 A 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 A 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 A 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 A 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 A 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 A 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 A 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 A 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 A 262 LEU LYS SEQRES 1 B 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 B 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 B 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 B 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 B 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 B 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 B 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 B 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 B 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 B 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 B 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 B 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 B 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 B 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 B 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 B 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 B 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 B 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 B 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 B 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 B 262 LEU LYS HET NAD A 301 44 HET AYM A 302 24 HET NAD B 401 44 HET AYM B 402 24 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM AYM 3-(6-AMINOPYRIDIN-3-YL)-N-METHYL-N-[(1-METHYL-1H-INDOL- HETNAM 2 AYM 2-YL)METHYL]ACRYLAMIDE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 AYM 2(C19 H20 N4 O) FORMUL 7 HOH *300(H2 O) HELIX 1 1 SER A 19 GLU A 31 1 13 HELIX 2 2 ASN A 41 LEU A 55 1 15 HELIX 3 3 GLU A 67 TRP A 82 1 16 HELIX 4 4 PRO A 96 ASP A 101 5 6 HELIX 5 5 ASP A 103 VAL A 108 1 6 HELIX 6 6 THR A 109 SER A 121 1 13 HELIX 7 7 SER A 121 ARG A 132 1 12 HELIX 8 8 SER A 133 LEU A 135 5 3 HELIX 9 9 TYR A 146 GLU A 150 5 5 HELIX 10 10 ASN A 157 GLY A 178 1 22 HELIX 11 11 PHE A 203 THR A 214 1 12 HELIX 12 12 THR A 221 CYS A 233 1 13 HELIX 13 13 SER A 234 ALA A 238 5 5 HELIX 14 14 GLY A 250 ALA A 254 5 5 HELIX 15 15 SER B 19 GLU B 31 1 13 HELIX 16 16 ASN B 41 LEU B 55 1 15 HELIX 17 17 GLU B 67 TRP B 82 1 16 HELIX 18 18 PRO B 96 LEU B 100 5 5 HELIX 19 19 ASP B 103 VAL B 108 1 6 HELIX 20 20 THR B 109 SER B 121 1 13 HELIX 21 21 SER B 121 ARG B 132 1 12 HELIX 22 22 TYR B 146 GLU B 150 5 5 HELIX 23 23 TYR B 156 GLY B 178 1 23 HELIX 24 24 PHE B 203 THR B 214 1 12 HELIX 25 25 THR B 221 SER B 234 1 14 HELIX 26 26 ASP B 235 ALA B 238 5 4 HELIX 27 27 GLY B 250 ALA B 254 5 5 SHEET 1 A 7 VAL A 60 GLN A 62 0 SHEET 2 A 7 GLU A 34 TYR A 39 1 N PHE A 37 O LEU A 61 SHEET 3 A 7 ARG A 8 VAL A 11 1 N VAL A 11 O ALA A 36 SHEET 4 A 7 PHE A 88 HIS A 90 1 O VAL A 89 N LEU A 10 SHEET 5 A 7 SER A 139 SER A 145 1 O LEU A 142 N HIS A 90 SHEET 6 A 7 VAL A 182 ALA A 189 1 O ARG A 183 N LEU A 141 SHEET 7 A 7 VAL A 244 VAL A 247 1 O VAL A 247 N SER A 188 SHEET 1 B 7 VAL B 60 GLN B 62 0 SHEET 2 B 7 GLU B 34 TYR B 39 1 N PHE B 37 O LEU B 61 SHEET 3 B 7 ARG B 8 VAL B 11 1 N VAL B 11 O ALA B 36 SHEET 4 B 7 PHE B 85 HIS B 90 1 O VAL B 89 N LEU B 10 SHEET 5 B 7 LEU B 135 SER B 145 1 O LEU B 142 N HIS B 90 SHEET 6 B 7 VAL B 182 ALA B 189 1 O ILE B 187 N SER B 145 SHEET 7 B 7 VAL B 244 VAL B 247 1 O VAL B 245 N SER B 188 SITE 1 AC1 24 GLY A 13 ALA A 15 SER A 19 ILE A 20 SITE 2 AC1 24 GLN A 40 CYS A 63 ASP A 64 VAL A 65 SITE 3 AC1 24 SER A 91 ILE A 92 GLY A 93 LEU A 144 SITE 4 AC1 24 SER A 145 LYS A 163 ALA A 189 GLY A 190 SITE 5 AC1 24 ILE A 192 THR A 194 AYM A 302 HOH A 321 SITE 6 AC1 24 HOH A 366 HOH A 398 HOH A 399 HOH A 443 SITE 1 AC2 28 GLY B 13 ALA B 15 SER B 19 ILE B 20 SITE 2 AC2 28 GLN B 40 LEU B 44 CYS B 63 ASP B 64 SITE 3 AC2 28 VAL B 65 SER B 91 ILE B 92 GLY B 93 SITE 4 AC2 28 ILE B 119 LEU B 144 SER B 145 LYS B 163 SITE 5 AC2 28 ALA B 189 GLY B 190 PRO B 191 ILE B 192 SITE 6 AC2 28 THR B 194 LEU B 195 AYM B 402 HOH B 408 SITE 7 AC2 28 HOH B 412 HOH B 438 HOH B 470 HOH B 523 SITE 1 AC3 9 PHE A 94 ALA A 95 LEU A 100 TYR A 146 SITE 2 AC3 9 PRO A 154 ASN A 155 TYR A 156 MET A 206 SITE 3 AC3 9 NAD A 301 SITE 1 AC4 7 PHE B 94 ALA B 95 TYR B 146 PRO B 154 SITE 2 AC4 7 TYR B 156 NAD B 401 HOH B 545 CRYST1 79.580 79.580 326.170 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012566 0.007255 0.000000 0.00000 SCALE2 0.000000 0.014510 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003066 0.00000